• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全身 SUVmax 在 F-18 FDG PET/CT 中预测晚期卵巢癌初次肿瘤细胞减灭术时不理想减瘤的能力。

The ability of whole-body SUVmax in F-18 FDG PET/CT to predict suboptimal cytoreduction during primary debulking surgery for advanced ovarian cancer.

机构信息

Department of Obstetrics and Gynecology, School of Medicine, Kyungpook National University, Daegu, 41944, Republic of Korea.

Molecular Diagnostics and Imaging Center, School of Medicine, Kyungpook National University, Daegu, 41944, Republic of Korea.

出版信息

J Ovarian Res. 2019 Feb 4;12(1):12. doi: 10.1186/s13048-019-0488-2.

DOI:10.1186/s13048-019-0488-2
PMID:30717813
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6360666/
Abstract

BACKGROUND

The aim of this study was to (1) evaluate the ability of F-18 fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) parameters to predict suboptimal cytoreduction and (2) to create a risk model for predicting suboptimal cytoreduction in advanced ovarian cancer. From 2011 to 2015, 51 patients underwent primary cytoreductive surgery for advanced ovarian cancer were enrolled. A residual disease with maximal diameter >  1 cm was considered a suboptimal surgical result. The SUVmax values for nine abdominal regions, the sum of 9 regional SUVmax (WB1SUVmax) and WB2SUVmax (WB1SUVmax plus SUVmax of lymph nodes) were used for PET parameter. Multiple logistic regression analysis was used to determine the predictive value of PET and clinical parameters for risk model. In addition, assessments of disease-free survival (DFS) and overall survival (OS) were performed.

RESULTS

Seventeen of the 51 patients (33.3%) underwent suboptimal cytoreduction. The ECOG status (OR, 4.091), SUVmax of central (OR, 5.250), right upper (OR, 4.148), left upper (OR, 5.921) and WB2SUVmax (OR, 4.148) were associated with suboptimal cytoreduction. The risk model can divide the risk groups of suboptimal cytoreduction (area under the curve (AUC), 0.775; p = 0.0001). The DFS and OS in the high-risk group were significantly worse than those in the low-risk group (p = 0.0379 for DFS; p = 0.0211 for OS).

CONCLUSIONS

The presence of hypermetabolic lesions in the central, right upper, and left upper regions showed predictive value for suboptimal cytoreduction. Our risk model may be helpful for selecting patients who may show suboptimal cytoreduction.

摘要

背景

本研究旨在:(1)评估 18F 氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描(FDG PET/CT)参数预测不完全肿瘤减灭术的能力,(2)建立预测晚期卵巢癌不完全肿瘤减灭术的风险模型。2011 年至 2015 年,51 例晚期卵巢癌患者接受了初次细胞减灭术。最大直径>1cm 的残留疾病被认为是手术结果不理想。9 个腹部区域的 SUVmax 值、9 个区域 SUVmax 的总和(WB1SUVmax)和 WB2SUVmax(WB1SUVmax 加淋巴结 SUVmax)用于 PET 参数。采用多因素逻辑回归分析确定 PET 和临床参数对风险模型的预测价值。此外,还进行了无病生存(DFS)和总生存(OS)评估。

结果

51 例患者中有 17 例(33.3%)接受了不完全肿瘤减灭术。ECOG 状态(OR,4.091)、中央(OR,5.250)、右上(OR,4.148)、左上(OR,5.921)和 WB2SUVmax(OR,4.148)与不完全肿瘤减灭术相关。风险模型可以将不完全肿瘤减灭术的风险组(曲线下面积(AUC),0.775;p=0.0001)。高危组的 DFS 和 OS 明显差于低危组(DFS 时 p=0.0379;OS 时 p=0.0211)。

结论

中央、右上和左上区域的高代谢病变存在对不完全肿瘤减灭术具有预测价值。我们的风险模型可能有助于选择可能表现为不完全肿瘤减灭术的患者。

相似文献

1
The ability of whole-body SUVmax in F-18 FDG PET/CT to predict suboptimal cytoreduction during primary debulking surgery for advanced ovarian cancer.全身 SUVmax 在 F-18 FDG PET/CT 中预测晚期卵巢癌初次肿瘤细胞减灭术时不理想减瘤的能力。
J Ovarian Res. 2019 Feb 4;12(1):12. doi: 10.1186/s13048-019-0488-2.
2
FDG-PET/CT to predict optimal primary cytoreductive surgery in patients with advanced ovarian cancer: preliminary results.18F-氟脱氧葡萄糖正电子发射断层显像/计算机断层扫描预测晚期卵巢癌患者的最佳初次肿瘤细胞减灭术:初步结果
Tumori. 2016 Jan-Feb;102(1):103-7. doi: 10.5301/tj.5000396. Epub 2015 Aug 4.
3
Diagnostic value of integrated ¹⁸F-fluoro-2-deoxyglucose positron emission tomography/computed tomography in recurrent epithelial ovarian cancer: accuracy of patient selection for secondary cytoreduction in 134 patients.¹⁸F-氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描在复发性上皮性卵巢癌中的诊断价值:134 例患者二次细胞减灭术患者选择的准确性。
J Gynecol Oncol. 2018 May;29(3):e36. doi: 10.3802/jgo.2018.29.e36. Epub 2018 Feb 1.
4
Preoperative PET/CT score can predict incomplete resection after debulking surgery for advanced serous ovarian cancer better than CT score, MTV, tumor markers and hematological markers.术前 PET/CT 评分比 CT 评分、MTV、肿瘤标志物和血液标志物更能预测晚期浆液性卵巢癌肿瘤细胞减灭术后的不完全切除。
Acta Obstet Gynecol Scand. 2022 Nov;101(11):1315-1327. doi: 10.1111/aogs.14442. Epub 2022 Aug 18.
5
The role of F18-FDG PET/CT in predicting secondary optimal de-bulking in patients with recurrent ovarian cancer.F18-FDG PET/CT在预测复发性卵巢癌患者二次最佳肿瘤细胞减灭术中的作用。
Surg Oncol. 2017 Dec;26(4):347-351. doi: 10.1016/j.suronc.2017.07.004. Epub 2017 Jul 13.
6
Prediction of suboptimal primary cytoreduction in primary ovarian cancer with combined positron emission tomography/computed tomography--a prospective study.正电子发射断层扫描/计算机断层扫描联合用于预测原发性卵巢癌初次肿瘤细胞减灭术效果欠佳——一项前瞻性研究
Gynecol Oncol. 2008 Feb;108(2):265-70. doi: 10.1016/j.ygyno.2007.11.002. Epub 2007 Dec 4.
7
Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinoma.治疗前 18F-FDG PET/CT 最大标准化摄取值对局部晚期头颈部鳞状细胞癌的预后价值。
Clin Transl Oncol. 2017 Nov;19(11):1337-1349. doi: 10.1007/s12094-017-1674-6. Epub 2017 May 24.
8
F-FDG PET/CT as predictor of tumour biology and prognosis in epithelial ovarian carcinoma.F-FDG PET/CT作为上皮性卵巢癌肿瘤生物学和预后的预测指标
Rev Esp Med Nucl Imagen Mol. 2017 Jul-Aug;36(4):233-240. doi: 10.1016/j.remn.2017.01.004. Epub 2017 Mar 9.
9
FDG-PET/CT in advanced ovarian cancer staging: value and pitfalls in detecting lesions in different abdominal and pelvic quadrants compared with laparoscopy.在晚期卵巢癌分期中 FDG-PET/CT:与腹腔镜相比,在检测不同腹部和盆腔象限病变中的价值和陷阱。
Eur J Radiol. 2011 Nov;80(2):e98-103. doi: 10.1016/j.ejrad.2010.07.013. Epub 2010 Aug 4.
10
Development and Validation of 18F-FDG PET/CT-Based Models for Predicting Successful Complete Cytoreduction During Primary Cytoreductive Surgery for Advanced Ovarian cancer.基于18F-FDG PET/CT的模型在预测晚期卵巢癌初次肿瘤细胞减灭术中成功实现完全肿瘤细胞减灭的开发与验证
Clin Nucl Med. 2023 Feb 1;48(2):e51-e59. doi: 10.1097/RLU.0000000000004417. Epub 2022 Sep 30.

引用本文的文献

1
PET/CT Volumetric Parameters as Predictors of the Peritoneal Cancer Index in Advanced Ovarian Cancer Patients.PET/CT体积参数作为晚期卵巢癌患者腹膜癌指数的预测指标
Diagnostics (Basel). 2025 Jul 19;15(14):1818. doi: 10.3390/diagnostics15141818.
2
Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: ASCO Guideline Update.新诊断晚期卵巢癌的新辅助化疗:美国临床肿瘤学会指南更新
J Clin Oncol. 2025 Mar;43(7):868-891. doi: 10.1200/JCO-24-02589. Epub 2025 Jan 22.
3
Predicting Complete Cytoreduction with Preoperative [F]FDG PET/CT in Patients with Ovarian Cancer: A Systematic Review and Meta-Analysis.

本文引用的文献

1
The role of neoadjuvant chemotherapy followed by interval debulking surgery in advanced ovarian cancer: a systematic review and meta-analysis of randomized controlled trials and observational studies.新辅助化疗后行间歇性肿瘤细胞减灭术在晚期卵巢癌中的作用:一项对随机对照试验和观察性研究的系统评价与荟萃分析
Oncotarget. 2017 Dec 27;9(9):8614-8628. doi: 10.18632/oncotarget.23808. eCollection 2018 Feb 2.
2
F-18 FDG PET/CT metabolic tumor volume predicts overall survival in patients with disseminated epithelial ovarian cancer.F-18氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描代谢肿瘤体积可预测播散性上皮性卵巢癌患者的总生存期。
Eur J Radiol. 2017 Aug;93:107-113. doi: 10.1016/j.ejrad.2017.05.036. Epub 2017 May 30.
3
术前[F]FDG PET/CT预测卵巢癌患者的完全细胞减灭术:一项系统评价和荟萃分析
Diagnostics (Basel). 2024 Aug 10;14(16):1740. doi: 10.3390/diagnostics14161740.
4
Assessment of Intraoperative Scoring Systems for Predicting Cytoreduction Outcome in Peritoneal Metastatic Disease: A Systematic Review and Meta-analysis.评估预测腹膜转移疾病细胞减灭术结局的术中评分系统:系统评价和荟萃分析。
Ann Surg Oncol. 2024 Oct;31(10):7165-7183. doi: 10.1245/s10434-024-15629-7. Epub 2024 Jun 25.
5
Role of Positron Emission Tomography/Computed Tomography in Epithelial Ovarian Cancer.正电子发射断层扫描/计算机断层扫描在上皮性卵巢癌中的作用
Indian J Nucl Med. 2023 Oct-Dec;38(4):366-375. doi: 10.4103/ijnm.ijnm_42_22. Epub 2023 Dec 20.
6
Peritoneal Metastasis: A Dilemma and Challenge in the Treatment of Metastatic Colorectal Cancer.腹膜转移:转移性结直肠癌治疗中的困境与挑战
Cancers (Basel). 2023 Nov 29;15(23):5641. doi: 10.3390/cancers15235641.
7
Prediction of Surgical Outcome in Advanced Ovarian Cancer by Imaging and Laparoscopy: A Narrative Review.通过影像学和腹腔镜检查预测晚期卵巢癌的手术结果:一项叙述性综述
Cancers (Basel). 2023 Mar 22;15(6):1904. doi: 10.3390/cancers15061904.
8
Preoperative PET/CT score can predict incomplete resection after debulking surgery for advanced serous ovarian cancer better than CT score, MTV, tumor markers and hematological markers.术前 PET/CT 评分比 CT 评分、MTV、肿瘤标志物和血液标志物更能预测晚期浆液性卵巢癌肿瘤细胞减灭术后的不完全切除。
Acta Obstet Gynecol Scand. 2022 Nov;101(11):1315-1327. doi: 10.1111/aogs.14442. Epub 2022 Aug 18.
9
Surgery in Advanced Ovary Cancer: Primary versus Interval Cytoreduction.晚期卵巢癌手术:初次减瘤术与间隔期减瘤术
Diagnostics (Basel). 2022 Apr 14;12(4):988. doi: 10.3390/diagnostics12040988.
10
EANM guideline on the role of 2-[F]FDG PET/CT in diagnosis, staging, prognostic value, therapy assessment and restaging of ovarian cancer, endorsed by the American College of Nuclear Medicine (ACNM), the Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the International Atomic Energy Agency (IAEA).EANM 指南:2-[F]FDG PET/CT 在卵巢癌诊断、分期、预后价值、治疗评估和再分期中的作用,得到了美国核医学学院 (ACNM)、核医学与分子成像学会 (SNMMI) 和国际原子能机构 (IAEA) 的认可。
Eur J Nucl Med Mol Imaging. 2021 Sep;48(10):3286-3302. doi: 10.1007/s00259-021-05450-9. Epub 2021 Jul 3.
Epidemiologic factors that predict long-term survival following a diagnosis of epithelial ovarian cancer.
预测上皮性卵巢癌诊断后长期生存的流行病学因素。
Br J Cancer. 2017 Mar 28;116(7):964-971. doi: 10.1038/bjc.2017.35. Epub 2017 Feb 16.
4
Definition of a dynamic laparoscopic model for the prediction of incomplete cytoreduction in advanced epithelial ovarian cancer: proof of a concept.定义一个动态腹腔镜模型,用于预测晚期上皮性卵巢癌的不完全肿瘤细胞减灭术:概念验证。
Gynecol Oncol. 2015 Oct;139(1):5-9. doi: 10.1016/j.ygyno.2015.07.095. Epub 2015 Jul 18.
5
Volume-based quantitative FDG PET/CT metrics and their association with optimal debulking and progression-free survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery.基于容积的定量氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描(FDG PET/CT)指标及其与接受二次细胞减灭术的复发性卵巢癌患者最佳肿瘤细胞减灭和无进展生存期的关联。
Eur Radiol. 2015 Nov;25(11):3348-53. doi: 10.1007/s00330-015-3729-9. Epub 2015 Apr 28.
6
Predictors of optimal cytoreduction in patients with newly diagnosed advanced-stage epithelial ovarian cancer: Time to incorporate laparoscopic assessment into the standard of care.新诊断晚期上皮性卵巢癌患者最佳肿瘤细胞减灭术的预测因素:是时候将腹腔镜评估纳入护理标准了。
Gynecol Oncol. 2015 Jun;137(3):553-8. doi: 10.1016/j.ygyno.2015.03.049. Epub 2015 Mar 28.
7
Global cancer statistics, 2012.全球癌症统计数据,2012 年。
CA Cancer J Clin. 2015 Mar;65(2):87-108. doi: 10.3322/caac.21262. Epub 2015 Feb 4.
8
A multicenter prospective trial evaluating the ability of preoperative computed tomography scan and serum CA-125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube, and peritoneal cancer.一项多中心前瞻性研究,评估术前 CT 扫描和血清 CA-125 预测晚期卵巢癌、输卵管癌和腹膜癌初次肿瘤细胞减灭术时非理想减瘤的能力。
Gynecol Oncol. 2014 Sep;134(3):455-61. doi: 10.1016/j.ygyno.2014.07.002. Epub 2014 Jul 11.
9
Clinical utility of positron emission tomography/computed tomography in the evaluation of suspected recurrent ovarian cancer in the setting of normal CA-125 levels.正电子发射断层扫描/计算机断层扫描在 CA-125 水平正常的疑似复发性卵巢癌评估中的临床应用。
Int J Gynecol Cancer. 2010 Aug;20(6):936-44. doi: 10.1111/IGC.0b013e3181e82a7f.
10
Peritoneal carcinomatosis from ovarian cancer: the role of CT and [¹⁸F]FDG-PET/CT.卵巢癌腹膜转移瘤:CT及[¹⁸F]FDG-PET/CT的作用
Abdom Imaging. 2010 Dec;35(6):701-7. doi: 10.1007/s00261-009-9578-8.